Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Drexel University
With
National Institute of Mental Health (NIMH)
Oui Therapeutics, Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Are English speaking male or female
2. Are aged 18-70 years
3. Have recurrent objective or subjective binge eating episodes (≥12 episodes in 3 months)
4. Have BMI ≥30
5. Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
6. Are willing and able to complete enrollment procedures
7. Are able to understand the nature of the study and provide written informed consent
You may not be if
1. Are unable to fluently speak, write and read English.
2. Are already receiving treatment for an eating disorder (e.g., research participants cannot be receiving concurrent eating disorder treatment from another provider)
3. Are receiving weight loss treatment (behavioral or pharmacological)
4. Have a mental handicap or are currently experiencing severe psychopathology that would limit their ability to engage in study (e.g., imminent or high risk for suicide, substance use disorder, active psychotic disorder,)
5. Are purging and/or using laxatives 3 or more times per week and are not deemed safe for remote treatment by a primary care provider.
6. Are exercising 2 or more hours a day on average, or engaging in significantly harmful compensatory behaviors (i.e., \> 3x/week of self-induced vomiting or laxative use), and are not deemed safe for remote treatment by a primary care provider.
7. Are fasting for 24 hours or more, \> 3x times a week, and are not deemed safe for remote treatment by a primary care provider.
8. Are unwilling to receive medical clearance and/or medical monitoring as requested by the study to ensure they are medically safe to participate.
9. Are pregnant or planning to become pregnant within the next year.
10. Are individuals who are not yet adults (infants, children, teenagers) Are currently taking any of these medications: Haldol, Loxitane, Mellaril, Moban, Navane, Prolixin, Serentil, Stelaxine, Trilafon, Thoraxine, Abilify, Clozaril, Geodon, Risperdal, Seroquel, Zyprexa
